The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial
Open accessAbstract
Objectives This was a retrospective analysis to determine the effect of diabetes on outcome in patients with advanced heart failure (HF), and to determine the effect of beta-blockade in patients with HF with and without diabetes mellitus.Background In chronic HF the impact on clinical outcomes and therapeutic response of the prevalent comorbid condition diabetes mellitus has not been extensively investigated.Methods We assessed the impact of diabetes on prognosis and effectiveness of beta-blocker therapy with bucindolol in patients with HF enrolled in the Beta-Blocker Evaluation of Survival Trial (BEST). We conducted a retrospective analysis to examine the prognosis of patients with advanced HF with and without diabetes, and the effect of beta-blocker therapy on mortality and HF progression or myocardial infarction (MI). The database was the 2,708 patients with advanced HF (36% with diabetes and 64% without diabetes) who were randomized to the beta-blocker bucindolol or placebo in BEST and followed for mortality, hospitalization, and MI for an average of two years.Results Patients with diabetes had more severe chronic HF and more coronary risk factors than patients without diabetes. Diabetes was independently associated with increased mortality in patients with ischemic cardiomyopathy (adjusted hazard ratio 1.33, 95% confidence interval 1.12 to 1.58, p = 0.001), but not in those with a nonischemic etiology (adjusted hazard ratio 0.98, 95% confidence interval 0.74 to 1.30, p = 0.89). Compared with patients without diabetes, in diabetic patients beta-blocker therapy was at least as effective in reducing death or HF hospitalizations, total hospitalizations, HF hospitalizations, and MI. Ventricular function and physiologic responses to beta-blockade were similar in patients with and without diabetes.Conclusions Diabetes worsens prognosis in patients with advanced HF, but this worsening appears to be limited to patients with ischemic cardiomyopathy. In advanced HF beta-blockade is effective in reducing major clinical end points in patients with and without diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Compared with placebo, empagliflozin reduced the risk of the primary outcome, a composite of CV death or hospitalization for HF, by 21%, which was mainly related to a 29% lower risk of hospitalization for HF.530”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [530]
In the citing paper
“In three early clinical trials (SOLVD, 98 BEST, 94 and DIG 102 )t h er i s k appeared to be confined to those with an ischaemic aetiology.”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [94]
In the citing paper
“The majority of the available data suggests that T2DM is associated with higher risk of mortality in both patients of ischaemic and non-ischaemic aetiology (Table 6).29,88,94,96 -99”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [94]
In the citing paper
“In the BEST trial, T2DM was an independent risk factor for death from pump failure.94”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [94]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,109
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
Lechat, P. P., Brunhuber, K., Hofmann, R., Kuhn, P., Nesser, H., Slany, J., Weihs, W., Wiedermann, C. J., Wimmer, H., van Mieghem, W., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,922
Swedberg, K. B., & KJEKSHUS, J. K. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250502 · Cited by 2,833
Survival after the onset of congestive heart failure in Framingham Heart Study subjects.
Ho, K. K. L., Anderson, K. M., Kannel, W. B., Grossman, W., & Levy, D. A. (1993) · Circulation · doi:10.1161/01.cir.88.1.107 · Cited by 1,865
Hunt, S. A., Baker, D. W., Chin, M. H., Cinquegrani, M. P., Feldman, A. M., Francis, G. S., Ganiats, T. G., Goldstein, S., Gregoratos, G., Jessup, M. L., et al. (2001) · Circulation · doi:10.1161/hc4901.102568 · Cited by 1,440
Diabetes and cardiovascular disease
Howard, B. V., & Magee, M. F. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0046-8 · Cited by 1,386
Research works printed but not linked: 4
- Schaffer, 1989, Basis for mechanical defects associated with non-insulin-dependent diabetes, Am J Physiol, 256, E25
- Domanski, 2001, A comparative analysis of the results of three trials of beta-blocker therapy for heart failure, J Cardiac Failure, 7, 56
- Sederberg, 2000, Bucindolol has no sympathomimetic activity in nonfailing ventricular preparations, J Am Coll Cardiol, 35, 207A
- Bristow, 1996, Effect of carvedilol on LV function and mortality in diabetic versus non-diabetic patients with ischemic or nonischemic dilated cardiomyopathy, Circulation, 94, I664
Cited by
Sorted by citations
Items 101–200 of 215
An Economic Evaluation of a Self-Care Intervention in Persons With Heart Failure and Diabetes
Reilly, C. M., Butler, J., Culler, S. D., GARY, R. A., Higgins, M. K., Schindler, P., Butts, B., & Dunbar, S. B. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.06.382 · Cited by 21
Prognostic Impact of Diabetes Mellitus in Patients With Acute Decompensated Heart Failure
Burger, A. J., Tsao, L., & Aronson, D. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.12.070 · Cited by 21
Zehnder, A. R., Carrasco, A. J. P., & Etkind, S. N. (2022) · Palliative Medicine · doi:10.1177/02692163221123422 · Cited by 19
Congestive heart failure in the elderly diabetic
Verny, C. (2007) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)80055-3 · Cited by 19
Reeves, G. C., Alhurani, A. S., Frazier, S. K., Watkins, J. F., Lennie, T. A., & Moser, D. K. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000077 · Cited by 19
Jorsal, A., Wiggers, H., & McMurray, J. J. V. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.007 · Cited by 20
Chazova, I. E., Shestakova, M. V., Zhernakova, Y. V., Blinova, N. V., Маркова, Т. Н., Mazurina, N. V., Владиславович, Е. М., Tereshchenko, S. N., Жиров, И. В., Komarov, A. L., et al. (2021) · Eurasian heart journal · doi:10.38109/2225-1685-2021-2-6-61 · Cited by 19
Fried, T. R., O’Leary, J. R., Towle, V. R., Goldstein, M. K., Trentelange, M., & Martin, D. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112593 · Cited by 19
Sung, P., Sun, C., Ko, S., Chang, L., Sheu, J., Lee, F.-Y., Wu, C., Chua, S. O., & Yip, H. (2009) · International Heart Journal · doi:10.1536/ihj.50.191 · Cited by 18
Rydén, L., estable, G. D. T. D. L. S. E. D. C. S. D. Y. T. D. L. C. I., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H. P., et al. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.10.015 · Cited by 20
Predicting Heart Failure Readmissions
Sherer, A. P., Crane, P. B., Abel, W. M., & Efird, J. T. (2014) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000225 · Cited by 17
Novel insight into the dangerous connection between diabetes and heart failure
Lombardi, C., Spigoni, V., Gorga, E., & Dei, A. (2016) · Herz · doi:10.1007/s00059-016-4415-7 · Cited by 17
Julián, M. T., Alonso, N., Lupón, J., Gavidia‐Bovadilla, G., Ferrer, E., de Antonio, M., López‐Ayerbe, J., Domingo, M., Santiago‐Vacas, E., Zamora, E., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01011-w · Cited by 17
Anguita, M. P., Bayés‐Genís, A., Cepeda, J. M., Cinza‐Sanjurjo, S., Cosín, J., Leiro, M. C., Egocheaga, I., Escobar, C., Faraudo, M., García-Pinilla, J. M., et al. (2020) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(20)30016-9 · Cited by 16
Heart Failure in the Diabetic Patient
Bell, D. S. H. (2007) · Cardiology Clinics · doi:10.1016/j.ccl.2007.08.003 · Cited by 16
Time to Address the Cardiac Metabolic “Triple Whammy”
Horowitz, J. D., & Kennedy, J. A. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.010 · Cited by 16
Impaired Fasting Glucose: A Predictor of Reduced Survival in Patients with Heart Failure
Gotsman, I., Shauer, A., Lotan, C., & Keren, A. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.146 · Cited by 16
Pharmacological interventions for heart failure in people with chronic kidney disease
Ravani, P., Quinn, R. R., & Strippoli, G. F. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012466 · Cited by 16
Bucindolol: A Pharmacogenomic Perspective on its Use in Chronic Heart Failure
Smart, N. A., Kwok, N., Holland, D. J., Jayasighe, R., & Giallauria, F. (2011) · Clinical Medicine Insights Cardiology · doi:10.4137/cmc.s4309 · Cited by 15
Blood pressure targets for hypertension in patients with type 2 diabetes
Aronow, W. S., & Shamliyan, T. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.04.36 · Cited by 15
Miura, M., Sakata, Y., Miyata, S., Nochioka, K., Takada, T., Tadaki, S., Ushigome, R., Yamauchi, T., Sato, K., Onose, T., et al. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0096 · Cited by 14
Revisiting the Diabetes-Heart Failure Connection
Wallner, M., Eaton, D., von Lewinski, D., & Sourij, H. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1116-z · Cited by 14
Key factors of diastolic dysfunction and abnormal left ventricular relaxation in diabetic rats
Kitpipatkun, P., Matsuura, K., Shimada, K., Uemura, A., Goya, S., Yoshida, T., Ma, D., Takahashi, K., & Tanaka, R. (2020) · Journal of Medical Ultrasonics · doi:10.1007/s10396-020-01021-x · Cited by 14
The Role of NT PRO-BNP in the Evaluation of Diabetic Patients with Heart Failure
Frîngu, F. I. (2020) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2020.183 · Cited by 14
Diabetic cardiomyopathy: factual or factoid?
Quinaglia, T., de Oliveira, D. C., Matos‐Souza, J. R., & Sposito, A. C. (2019) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.65.1.69 · Cited by 13
Lee, R., Chan, S., Wong, J. S., Lau, D., Ho, K.-T., & Ng, K. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.11.139 · Cited by 12
Rørth, R., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L. M., Korup, E., Signorovitch, J., Bruun, N. E., Eiskjær, H., Hassager, C., et al. (2019) · EP Europace · doi:10.1093/europace/euz114 · Cited by 11
Piccini, J. P., Connolly, S. J., Abraham, W. T., Healey, J. S., Steinberg, B. A., Al‐Khalidi, H. R., Dignacco, P., van Veldhuisen, D. J., Sauer, W. H., White, M., et al. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.12.001 · Cited by 11
Self-citationMagnesium deficiency in heart failure patients with diabetes mellitus.
Shaikh, S., & Karira, K. A. (2011) · PubMed · Cited by 11
CHOP deficiency inhibits methylglyoxal-induced endothelial dysfunction
Choi, Y. Y., Kim, S., Han, J.-H., Nam, D.-H., Park, K. M., Kim, S. Y., & Woo, C.-H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.051 · Cited by 10
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Iyer, N. R., Chan, S.-P., Liew, O. W., Ching, J. C. P., Bryant, J., Thu-Thao, L., Chandramouli, C., Cozzone, P. J., Eisenhaber, F., Foo, R., et al. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-03810-5 · Cited by 9
Tricò, D., Baldi, S., Frascerra, S., Venturi, E., Marraccini, P., Neglia, D., & Natali, A. (2015) · Journal of Diabetes Research · doi:10.1155/2016/3906425 · Cited by 9
Formiga, F., Chivite, D., Montero, A., Petit, I., Moreno‐González, R., Franco, J., & Corbella, X. (2017) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13215 · Cited by 8
Double trouble: managing diabetic emergencies in patients with heart failure
Philip, L., & Poole, R. (2018) · Practical Diabetes · doi:10.1002/pdi.2181 · Cited by 8
EASD, E. (2013) · Kardiologia Polska · doi:10.5603/kp.2013.0289 · Cited by 9
Glycated Hemoglobin and Outcomes of Heart Failure (from Get With the Guidelines-Heart Failure)
Echouffo-Tcheugui, J. B., Sheng, S., DeVore, A. D., Matsouaka, R., Hernandez, A. F., Yancy, C. W., Heidenreich, P. A., Bhatt, D. L., & Fonarow, G. C. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.11.023 · Cited by 8
La diabetes mellitus tipo 2 como enfermedad cardiovascular
Anchuelo, A. C., Pinto, R. C., & Serrano‐Ríos, M. (2007) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(07)75231-7 · Cited by 8
Is the Blood Pressure Paradox Observed in All Heart Failure Patients?
Cunha, F. M., Lourenço, P., Reina‐Couto, M., Tavares, P., Silva, S. C. P. D., Guimarães, J. T., & Bettencourt, P. (2013) · BioMed Research International · doi:10.1155/2013/350289 · Cited by 7
Heart Failure and Diabetes Mellitus: Defining the Problem and Exploring the Interrelationship
Wilkinson, M. J., Zadourian, A., & Taub, P. R. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.08.004 · Cited by 7
The role of glycemia in acute heart failure patients
Seferović, J. P., Milinković, I., Tesic, M. B., Ristić, A. D., Lalic, N. M., Simeunović, D. S., Živković, I., Somma, S. D., & Seferovic, P. M. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0239 · Cited by 7
Марданов, Б. У., Korneeva, M., & Akhmedova, E. B. (2016) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2016-12-6-743-748 · Cited by 6
Lateef, N., Usman, M., Colombo, P. C., Ahmed, S., Khan, M. S., Khan, S. U., Garan, A. R., yuzefpolskaya, M., & Demmer, R. T. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.09.021 · Cited by 6
Prognostic impact of diabetes in chronic and acute heart failure
Ghio, S., Mercurio, V., Attanasio, A. F., Asile, G., Tocchetti, C. G., & Paolillo, S. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10193-8 · Cited by 6
Vrtovec, B., Fister, M., Poglajen, G., Starc, V., & Haddad, F. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.02272.x · Cited by 6
Effect of Cardiac Resynchronization Therapy in Patients with Diabetes Randomized in EchoCRT
Nägele, M. P., Steffel, J., Robertson, M., Singh, J. P., Flammer, A. J., Bax, J. J., BORER, J. S., Dickstein, K., Ford, I., Gorcsan, J., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.655 · Cited by 6
Chia, Y. M. F., Teng, T. K., Chandramouli, C., Yap, J. J. L., MacDonald, M. R., & Lam, C. S. P. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9672-5 · Cited by 6
Diabetes mellitus, insuficiencia cardíaca y mortalidad
Serrano‐Ríos, M., & Anchuelo, A. C. (2005) · Medicina Clínica · doi:10.1157/13077147 · Cited by 6
Heart Failure as a Consequence of Diabetic Cardiomyopathy
Buren, P. N. V., & LeWinter, M. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10026-9 · Cited by 5
Mandour, A. S., Farag, A. A. G., Helal, M., ElMasry, G. M., Al-Rejaie, S. S., Takahashi, K., Yoshida, T., Hamabe, L., & Tanaka, R. (2023) · Animals · doi:10.3390/ani13152452 · Cited by 5
Boutsikos, I., Beltsios, E. T., Schmack, B., Pantazopoulos, I. N., & Chatzis, D. (2023) · Heart International · doi:10.17925/hi.2023.17.2.12 · Cited by 5
Egom, E. E. A. (2013) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3283639755 · Cited by 5
Prevalent Diabetes Mellitus: Mortality and Management in Norwegian Heart Failure Outpatients
Stubnova, V., Os, I., Grundtvig, M., & Waldum-Grevbo, B. E. (2016) · Cardiology · doi:10.1159/000444658 · Cited by 5
Heart Failure in Diabetes mellitus: Clinical Features and Prognostic Implications
Gorelik, O., Almoznino‐Sarafian, D., Alon, I., Shteinshnaider, M., Chachashvily, S., Tzur, I., Modai, D., & Cohen, N. (2005) · Cardiology · doi:10.1159/000084587 · Cited by 5
New Directions in the Medical Management of Heart Failure
Harding, J. D., & Jessup, M. L. (2005) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2005.06.016 · Cited by 4
Siedlecki, Ł., Szyguła‐Jurkiewicz, B., Pyka, Ł., Król, B., Szczurek, W., & Gąsior, M. (2017) · Polish Journal of Cardio-Thoracic Surgery · doi:10.5114/kitp.2017.70530 · Cited by 4
Palliative radiotherapy utilization within a regional Australian palliative care unit
Eastman, P., Dowd, A., Goonan, J., Farrell, H. M., & Pitson, G. (2017) · Annals of Palliative Medicine · doi:10.21037/apm.2017.09.07 · Cited by 4
Steinke, P., Schupp, T., Kuhn, L., Abumayyaleh, M., Ayoub, M., Mashayekhi, K., Bertsch, T., Ayasse, N., Jannesari, M., Siegel, F. P., et al. (2024) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2024.12.001 · Cited by 3
Castelvecchio, S., Ranucci, M., Donato, M. D., & Menicanti, L. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2009.07.006 · Cited by 3
Egom, E. E. A. (2012) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944712457598 · Cited by 4
Ghio, S., Klersy, C., Carluccio, E., Scardovi, A. B., Scelsi, L., Falletta, C., Rossi, A., Faggiano, P. M., Traversi, E., Vriz, O., et al. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.07.008 · Cited by 3
Diabetes and the Cardiovascular System
Rigato, M., Fadini, G. P., & Avogaro, A. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_6-3 · Cited by 3
Insuficiencia cardíaca y diabetes
Thierer, J. M. (2026) · Revista Argentina de Cardiología · doi:10.7775/rac.v74i1.2642 · Cited by 3
Subauste, A. R., Esfandiari, N. H., Qu, Y., Oral, E. A., Aaronson, K. D., Pagani, F. D., & Gianchandani, R. Y. (2014) · Hospital Practice · doi:10.3810/hp.2014.08.1124 · Cited by 4
Antagonism of the Sympathetic Nervous System in Heart Failure
Metra, M., & Bristow, M. R. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10046-4 · Cited by 3
Self-citationHeart Failure as a Consequence of Ischemic Heart Disease
Flaherty, J. D., Bonow, R. O., & Gheorghiade, M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10023-3 · Cited by 3
Long‐term survival following the development of heart failure in an elderly hypertensive population
Sahle, B. W., Owen, A. J., Wing, L. M. H., Beilin, L. J., Krum, H., & Reid, C. M. (2017) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12303 · Cited by 3
Heart Failure as a Consequence of Ischemic Heart Disease
Felker, G. M., Mann, D. L., Flaherty, J. D., & Bonow, R. O. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-60987-6.00019-3 · Cited by 3
Beta-blockers in selected heart failure populations
Ghali, J. K. (2005) · Current Heart Failure Reports · doi:10.1007/s11897-005-0016-0 · Cited by 3
Self-citationSiddiqui, M. H., Dixit, R., Agarwal, S., Jha, S. C., Khanna, H., & Agrawal, S. K. (2024) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_701_23 · Cited by 2
Albackr, H. B., Albacker, T. B., Elshaer, F., Asfina, N., Subaie, F. A. A., Ullah, A. A., Hayajneh, A., Almogbel, O., Alayoubi, F., & Habeeb, W. A. (2022) · PubMed Central · Cited by 2
Gao, Z., Tomaselli, G. F., Wei, C., & Winslow, R. L. (2006) · Journal of Cardiothoracic-Renal Research · doi:10.1016/j.jccr.2005.12.002 · Cited by 2
Beta Blockade in Diabetic Heart Failure
Lukas, M. A. (2006) · Heart Failure Clinics · doi:10.1016/j.hfc.2005.11.005 · Cited by 2
Andersen, L. V., Wiinberg, N., Tuxen, C., & Kjær, A. (2011) · Diagnostics · doi:10.3390/diagnostics1010038 · Cited by 2
Natriuretic Peptide System Activation in Acute Heart Failure Patients with Diabetes
Cunha, F. M., Pereira, J. C., Marques, P. S., Moreira, H., Rodrigues, P., Pinto, M. J., Lourenço, P., & Bettencourt, P. (2017) · Journal of Diabetes Research · doi:10.1155/2017/1426705 · Cited by 2
Nonischaemic heart failure and diabetes mellitus
Shindler, D. M. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.02.028 · Cited by 2
Akwo, E. A. (2012) · WakeSpace Scholarship (Wake Forest University) · Cited by 2
Biochemical profile and prognosis of patients with heart failure and diabetes
Марданов, Б. У., Kokozheva, M. A., & Мамедов, М. Н. (2020) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2020-3841 · Cited by 1
Jurkiewicz, M., Szczurek, W., Skrzypek, M., Jozwiak, J. J., Gąsior, M., & Szyguła‐Jurkiewicz, B. (2025) · Biomedicines · doi:10.3390/biomedicines13082000 · Cited by 1
Systolic reconstruction in patients with low heart rate using coronary dual-source CT angiography
Okada, M., Nakashima, Y., Shigemoto, Y., Matsunaga, N., Miura, T., Nao, T., Sano, Y., Narazaki, A., & Kido, S. (2011) · European Journal of Radiology · doi:10.1016/j.ejrad.2011.01.104 · Cited by 1
Are we overtreating cardiovascular disease in diabetic patients
Mosseri, M., Arnson, Y., & Raz, I. (2013) · Diabetes Management · doi:10.2217/dmt.13.30 · Cited by 1
Cerdà, P., Franco, J., Chivite, D., & Formiga, F. (2016) · Revista Clínica Española · doi:10.1016/j.rce.2016.03.003 · Cited by 1
Rosa, G. M., Meliota, G., Brunelli, C., & Ferrero, S. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1291631 · Cited by 1
Beyramzadeh, M., Ansari, M. H. K., Azimzadeh, K., & Salami, S. (2017) · Journal of Pharmacy and Pharmacology · doi:10.17265/2328-2150/2017.010.002 · Cited by 1
USO ATUAL DE BETABLOQUEADORES: QUAIS PACIENTES REALMENTE SE BENEFICIAM?
Pinto, L. B. (2025) · EPITAYA eBooks · doi:10.47879/ed.ep.2025820p344
Dipeptidyl Peptidase-4 Inhibitors and Heart Failure: Friends or Foes?
Monami, M., & Mannucci, E. (2015) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-015-0465-2 · Cited by 1
Brown, S. H. M., & Abdelhafiz, A. H. (2009) · Therapy · doi:10.2217/thy.09.21 · Cited by 1
Elrayes, M. M., Abdelhady, A., elnady, E., & Elsafty, E. E. A. (2023) · Zagazig University Medical Journal · doi:10.21608/zumj.2023.174821.2690 · Cited by 1
Robinson, P. F., & Bristow, M. R. (2006) · doi:10.1002/9780470994740.ch5 · Cited by 1
Self-citationKein erhöhtes Mortalitätsrisiko durch Metformin-Therapie bei Diabetespatienten mit Herzinsuffizienz
Jecht, M. (2011) · Der Diabetologe · doi:10.1007/s11428-010-0679-3
Left Ventricular Reconstruction in Ischemic Heart Disease
Sartipy, U. (2007) · Figshare
Begum, N., Abdullah, A. S., Khan, M. A. H., Sultana, A. W., Osmany, D., & Mollah, F. H. (2014) · Chattagram Maa-O-Shishu Hospital Medical College Journal · doi:10.3329/cmoshmcj.v13i1.19409
Rydén, L., Grant, P. J., Bax, J. J., Fagard, R. H., Ferrari, R., Hasdai, D., Hoes, A. W., Kirchhof, P. F., Piepoli, M. F., Torbicki, A., et al. (2014)
Heart Failure and Cardiac Dysfunction in Diabetes
Young, L. H., Russell, R. R., & Chyun, D. A. (2005) · Humana Press eBooks · doi:10.1385/1-59259-908-7:555
Optimal glycemic control improves outcomes of chronic heart failure
(2007) · The Internet Journal of Cardiovascular Research · doi:10.5580/79f
Bayesian probability encoding in medical decision analysis
Pang, C. S. (2008) · National University of Singapore
Diabetic Cardiomyopathy: Cause or Consequence of Diabetes Mellitus?
Albarracin, M. L. G., & Chaparro, P. (2017) · Cardiology and Cardiovascular Medicine · doi:10.26502/fccm.92920020
Seguridad de los fármacos antidiabéticos en pacientes con insuficiencia cardiaca
Carrasco-Sánchez, F. J., Ostos-Ruiz, A. I., & Soto-Martín, M. (2017) · Revista Clínica Española · doi:10.1016/j.rce.2017.07.007
Metadata
- Authors
- Domanski, M., Krause-Steinrauf, H., Deedwania, P., Follmann, D., Ghali, J. K., Gilbert, E., Haffner, S., Katz, R., Lindenfeld, J., Lowes, B. D., Martin, W., McGrew, F., & Bristow, M. R.
- Affiliations
- National Institutes of Health (US)
- National Heart, Lung, and Blood Institute (US)
- Fresno VA Medical Center (US)
- University of Utah (US)
- The University of Texas at San Antonio Health Science Center (US)
- George Washington University (US)
- University of Colorado Denver (US)
- St. Louis VA Medical Center (US)
- Baptist Memorial Hospital (US)
- Corresponding author
- Domanski, Michael
- ORCID
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2003-09
- Volume
- 42
- Issue
- 5
- Pages
- 914-922
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2014986461
- Cited by
- 215
- References
- 34
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 18 · 2019: 10 · 2018: 13 · 2017: 17 · 2016: 12 · 2015: 10 · 2014: 17 · 2013: 9 · 2012: 10
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- National Heart, Lung, and Blood Institute
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Keywords
- diabetes mellitus, advanced heart failure, beta-blocker therapy, bucindolol, ischemic cardiomyopathy, mortality, heart failure hospitalization, myocardial infarction, prognosis, comorbidities
- MeSH terms
- Adrenergic beta-Antagonists, Adult, Aged, Aged, 80 and over, Cause of Death, Female, Heart Failure, Hospitalization, Humans, Male, Middle Aged, Prognosis, Propanolamines, Retrospective Studies, Risk Factors, Severity of Illness Index, Proportional Hazards Models, Survival Analysis, Heart Transplantation, Ventricular Function, Treatment Outcome, Disease Progression, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
